cbdMD (NYSEAMERICAN:YCBD) Stock Falls 0.7% – Time to Sell?

cbdMD, Inc. (NYSEAMERICAN:YCBD – Get Free Report)’s stock price dropped 0.7% on Thursday. The company traded as low as $0.3850 and last traded at $0.3924. 55,078 shares were traded during mid-day trading, a decline of 44% from the average daily volume of 98,209 shares. The stock had previously closed at $0.3950.

Wall Street Analysts Forecast Growth

Separately, Maxim Group lowered cbdMD from a “buy” rating to a “hold” rating in a research note on Monday, August 17th. One research analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Get Our Latest Stock Report on YCBD

cbdMD Stock Down 0.7%

The business’s 50 day moving average price is $0.42 and its 200-day moving average price is $0.64.

cbdMD (NYSEAMERICAN:YCBD – Get Free Report) last announced its earnings results on Thursday, August 13th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.08). The business had revenue of $5.55 million during the quarter, compared to analyst estimates of $5.69 million. cbdMD had a negative return on equity of 34.26% and a negative net margin of 13.80%.

About cbdMD

(Get Free Report)

cbdMD, Inc. is a consumer health and wellness company that develops, markets and sells cannabidiol (CBD) products. Its offerings include CBD oils and tinctures, gummies and other ingestible products, capsules, creams and other topical formulations, as well as products designed for pets. The company markets products under the cbdMD brand and has also offered pet-focused products under the Paw CBD name. Its portfolio is positioned for consumers seeking wellness, relaxation, recovery and everyday health-support products, subject to applicable regulations governing CBD and related ingredients. cbdMD primarily reaches customers through its direct-to-consumer e-commerce operations and retail distribution channels in the United States, with products also available through select additional markets and third-party sellers.

Further Reading

Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.